Comparing different analgesia drugs and techniques for extracorporeal shock wave lithotripsy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201012041310N5

Enrollment

108

Registered

2011-01-22

Start date

2010-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urolithiasis. Urolithiasis

Interventions

Intervention 1: Remifentanil /Target controlled infusion (TCI) 1 ng/ml as target dose. Intervention 2: Sufentanil /Target controlled infusion (TCI) 0.2ng/ml as target dose. Intervention 3: Sufentanil

Treatment - Drugs

Remifentanil /Target controlled infusion (TCI) 1 ng/ml as target dose

Sufentanil /Target controlled infusion (TCI) 0.2ng/ml as target dose

Sufentanil /Patient-controlled analgesia (PCA) loading dose= 0. 1 ng/kg and continue with 0.1ng/kg /hr

Morphinl /Patient-controlled analgesia (PCA) loading dose = 0.05mg/ml and maximum dose = 0.15mg/kg/hr

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- single stone in the caulis or in the ureter 2- ?age greater than 18 years, and less than 60 years 3- ASA ?-III, Exclusion criteria: 1-patients with one kidney, 2- having history of allergy, 3- having history of chronic consumption of analgesics or sedatives and any contraindication for prescribed of these drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of pain. Timepoint: 1. At the start of the wave, 2. during Urolithiasis, 3. at the end of the procedure. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Naser Yeganeh

Kermanshah University of Medical Sciences

nyeganeh@kums.ac.irnyeganeh@yahoo.com+98 83 1428 2670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026